Showing results (1631-1640 of 1,800) with videos related to
Sort By:
Pageof 180
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2017
Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health SystemsMei Lu, Jia Li, Irina V Haller, et al.Journal of Vascular and Interventional Radiology : JVIR|November 15, 2020
Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor ModelAndrew C Gordon, Vanessa L Gates, Sarah B White, et al.JAMA|October 26, 2022
Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial, John A Myburgh, Ian M Seppelt, et al.The Lancet. Gastroenterology & Hepatology|June 13, 2020
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label studyEric Lawitz, Charles S Landis, Steven L Flamm, et al.The Journal of Rheumatology|July 16, 1999
An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study GroupA E Clarke, M A Petri, S Manzi, et al.Virology|July 24, 2013
Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studiesRichard J O Barnard, John A Howe, Robert A Ogert, et al.American Journal of Respiratory and Critical Care Medicine|October 15, 2021
A Research Agenda for Precision Medicine in Sepsis and Acute Respiratory Distress Syndrome: An Official American Thoracic Society Research StatementFaraaz Ali Shah, Nuala J Meyer, Derek C Angus, et al.Hepatology (Baltimore, Md.)|June 22, 2010
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infectionAndrew J Muir, Mitchell L Shiffman, Atif Zaman, et al.Journal of Viral Hepatitis|February 11, 2019
Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infectionEric Lawitz, Fred Poordad, Leah J Anderson, et al.Journal of the American Chemical Society|December 20, 2022
Triplets with a Twist: Ultrafast Intersystem Crossing in a Series of Electron Acceptor Materials Driven by Conformational DisorderSai Shruthi Murali, Joseph K Gallaher, Céline Janiseck, et al.Pageof 180